Sjögren's syndrome. Proposed criteria for classificationRobert I. Fox, Francis V. Howelly, Charles A. Robinson et al.|Arthritis & Rheumatism|1986Cited by 685
Randomised trial of efficacy and safety of oral ganciclovir in the prevention of cytomegalovirus disease in liver-transplant recipientsEdward Gane, Charles A. Robinson, Faouzi Saliba et al.|The Lancet|1997Cited by 501
Oral Ganciclovir for Patients with Cytomegalovirus Retinitis Treated with a Ganciclovir ImplantDaniel Martín, Charles A. Robinson, Hong Li et al.|New England Journal of Medicine|1999Cited by 485
A Controlled Trial of Valganciclovir as Induction Therapy for Cytomegalovirus RetinitisDaniel Martín, Mary Jean Stempien, Charles A. Robinson et al.|New England Journal of Medicine|2002Cited by 394
Valganciclovir Results in Improved Oral Absorption of Ganciclovir in Liver Transplant RecipientsMark D. Pescovitz, Frances C. Brown, John M. Rabkin et al.|Antimicrobial Agents and Chemotherapy|2000Cited by 363